Posted inComunicati
Airway Therapeutics Closes $50 Million Equity Round to Advance Late-Stage Development of Zelpultide Alfa
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE ATLANTA, Aug. 25, 2026 /PRNewswire/ -- Airway Therapeutics, Inc., a…
diretta News